Consultant BMS

To deliver safe, effective and independent histopathology reporting in Cellular Pathology within an agreed Stage D scope of practice, alongside macroscopic dissection of relevant specimens. The post holder may present cases at MDT, provide expert advice to clinical teams, lead quality and audit activities to ISO 15189 standards, and support education, research and service development within an integrated team., o Timely, accurate and safe histopathology reports within agreed turnaround times.o Compliance with UKAS ISO 15189 and departmental QMS.o Effective MDT contribution and positive user feedback.o Demonstrable audit/quality improvement and education outputs., Partnership were c. £121m per annum with a workforce establishment of circa. 860 WTE.We strive to live by our WeCare values and are committed to promoting inclusion, where every staff member has a sense of belonging. We value our differences and fully advocate, cultivate and support an inclusive working environment.We particularly welcome applications from Black, Asian and minority ethnic candidates as they are underrepresented within the Pathology Partnership and Barts Health at this band

The NHS East and South East London Pathology Partnership is an arms-length organisation providing pathology services to Barts Health NHS Trust, Homerton Healthcare NHS Foundation Trust and Lewisham and Greenwich NHS Trust. The Pathology Partnership is hosted by Barts Health.The Pathology Partnership was formed in May 2021. Between 2021 and 2024 the Partnership undertook a complex transformation programme to establish a single network of laboratories, underpinned by a single Laboratory Information Management System (LIMS) and single Quality Management System (QMS).The Partnership has a main hub laboratory at the Royal London Hospital and Essential Service Laboratories (ESL) as a minimum at the six other hospital sites served by the Partnership.The Partnership has three operational divisions:o Blood Sciences including Haematology, Blood Transfusion and Biochemistryo Microbiology and Virologyo Cellular Pathology and Cancer DiagnosticsThe 2024/25 total operating costs across the